Skip to main content
View Cart

Journals in Oncology

  • Magnetic Resonance Imaging

    • ISSN: 0730-725X
    An International Journal of Basic Research and Clinical ApplicationsMagnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
    Subscriptions

  • Cytokine & Growth Factor Reviews

    • ISSN: 1359-6101
    Cytokine & Growth Factor Reviews publishes focused research reviews (state-of-the-art reviews, correspondence, perspectives, meeting reviews) devoted to important advances in fields of cytokine and growth factor research. Major emphasis will be placed on reviews that detail molecular mechanistic analysis of diverse areas of biomedical research, including cytokine regulation of immune responses, innate immunity, viral pathogenesis, inflammatory disorders including neuroinflammation, growth regulation in cancer, cytokines in the tumor microenvironment and cytokine-guided immunotherapeutic strategies. Priority will be given to those reviews with a focused expert perspective, provided by scientific leaders in their respective areas of research. Broad literature reviews with an overview perspective rather than a research focus should consider other Elsevier venues.
    Subscriptions

  • Critical Reviews in Oncology/Hematology

    • ISSN: 1040-8428
    Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world.The journal considers articles on the following themes:Basic Experimental OncologyCareer Development and Education in OncologyClinical ResearchHematologyIm... Pathology, Genomics and omics, and Liquid BiopsyPalliative SupportPediatric OncologyRadiotherapy... Ethics, and Health PolicySolid TumorsStatistics, Meta-analysis, and Clinical Trial DesignSurgeryCritica... Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy (ISLB).All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.
    Subscriptions

  • Oral Oncology

    • ISSN: 1368-8375
    A Journal Related to Head & Neck OncologyOral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngolog... plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes):• Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. • Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
    Subscriptions

  • Cancer Letters

    • ISSN: 0304-3835
    Cancer Letters is an international journal providing a forum for original and pertinent contributions in cancer research.Cancer Letters considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.
    Subscriptions

  • Experimental Hematology

    • ISSN: 0301-472X
    Journal for Hematology, Stem Cell Biology and TransplantationOffic... publication of the ISEH - International Society for Experimental HematologyExperiment... Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation. The goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment.The journal publishes topics including:Relevant developmental and aging processesStem cell biologyAnalyses of intrinsic and extrinsic regulatory mechanismsIn vitro behavior of primary cellsClonal trackingMolecular and omics analysesMetabolismEp... approachesStudies in model organismsNovel clinical observationsTranspla... biology and new therapeutic avenuesExperimental Hematology publishes two types of articles: Reviews and Perspectives and original findings sub-classified either as Brief Communications of significant singular results and Research Articles presenting the results of more developed studies.Experimental Hematology publishes Special Issues dedicated to important topics in the field. To view our Special Issues and article collections, click here.
    Subscriptions

  • Cytotherapy

    • ISSN: 1465-3249
    Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeutics.Design of novel therapeutic approaches employing cell/EV/gene products.Scientific mechanisms of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.Scientific mechanisms of action of toxicities attributable to cell/EV/gene therapiesIdentificat... of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.Important advances in cell/EV/gene-based product manufacturing and validation.Global/re... regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.Cytotherap... does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the field.Basic/translat... studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiology.Fund... scientific studies of normal or pathological processesStudies describing signaling pathways implicated in cancer.
    Subscriptions

  • Trends in Cancer

    • ISSN: 2405-8033
    Trends in Cancer is a new member of the Trends review journals, offering concise and engaging expert commentary articles that address key frontline research topics and cutting-edge advances in the rapidly changing field of cancer discovery and medicine. The journal provides a unique platform for multidisciplinary information, discussion and education that is valuable for scientists, clinicians, and policy makers, as well as patients and advocates. The latest opportunities, challenges and potential impact of basic, translational and clinical findings, industry R&D, technology and innovation, ethics, or cancer policy and funding are equally presented and debated in an authoritative but reader-friendly format.Critical issues to be covered in the journal include: Adult and Pediatric Cancers; Personalized Medicine; Tumor Microenvironment, Resistance and Metastasis; Immunotherapy; Metabolism; Genetics and Epigenetics; Diagnostics, Biomarkers and Treatment; Epidemiology and Cancer Prevention; Cancer related Ethics, Policy and Funding Initiatives.Visit the Cell Press website for more information about Trends in Cancer - http://www.cell.com/...
    Subscriptions

  • Lung Cancer

    • ISSN: 0169-5002
    An International Journal for Lung Cancer and other Thoracic Malignancies. An Official Journal of the European Society for Medical Oncology. The Official Journal of ETOP IBCSG Partners Foundation. The Official Journal of the British Thoracic Oncology GroupLung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.
    Subscriptions

  • The Lancet

    • ISSN: 0140-6736
    The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
    Subscriptions